endpoint-comparator-precedent

Report which primary endpoints the registered trials of an indication used and how often each succeeded or failed, by phase, and which control arms and active comparators those trials used and how they fared, from mondoTWIN's twin. Use when the user asks which endpoints work or have succeeded for a disease, for endpoint precedent or success rates by endpoint, what primary endpoint a phase 3 should use, which comparator or control arm trials in the indication used, the standard-of-care comparator, placebo versus active comparator, or what trials in an indication have measured. Descriptive precedent, not a prediction.